Patients on Eli Lilly’s next-generation obesity shot lost nearly 30% of their body weight on average in a trial that tracked them for a little more than a year—a result that’s far better than the most ...

Eli Lilly announced a $6 billion investment in a manufacturing campus in northern Alabama to boost production of its next-generation medicines for obesity and metabolic diseases. This project is part ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, in the past six months, driven not only by outstanding earnings and a notable margin increase, but also by reaching a $1T market cap and excitement ...

Indianapolis-based Eli Lilly is the first publicly traded U.S. healthcare company to reach market capitalization over $1 trillion, elevating the drugmaker to an exclusive list dominated by tech giants ...

Eli Lilly became the first healthcare company to hit a $1 trillion valuation (briefly on Nov. 21) Its diabetes and weight loss drugs are driving the rapid growth Demand for GLP-1 meds continues to ...

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eli Lilly achieved a $1 trillion market cap, a healthcare first, ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

The booming market for weight-loss drugs has propelled Eli Lilly LLY0.50%increase; green up pointing triangle to become the first pharmaceutical company to hit $1 trillion in market capitalization, ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold - the first drugmaker to ever reach that milestone. Eli Lilly & Co. is the first pharmaceutical stock to hit a $1 trillion valuation, ...

Nov. 21 (UPI) --Healthcare giant Eli Lilly on Friday became the first global healthcare company to hit $1 trillion in value. The Indiana-based company hit the $1 trillion market capitalization ...

The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...

Eli Lilly & Co. is the first pharmaceutical stock to hit a $1 trillion valuation, with its stock’s rise driven by a methodical approach to capturing an obesity-drug market that didn’t exist five years ...